Epidemiological Comparison of Four COVID-19 Waves in the Democratic Republic of the Congo, March 2020–January 2022

Author:

Otshudiema John OtokoyeORCID,Folefack Gervais Léon T.,Nsio Justus M.,Mbala-Kingebeni Placide,Kakema Cathy H.,Kosianza Joel B.,Mfumu Antoine K.,Saidi Guy N.,Kabongo Patrice M.,Okum Raphael,Tshimbombu Tshibambe N.,Ahuka-Mundeke Steve,Karamagi Humphrey CyprianORCID,Muyembe Jean-Jacques T.,Djiguimde Amédée Prosper

Abstract

Abstract Purpose Nationwide analyses are required to optimise and tailor activities to control future COVID-19 waves of resurgence continent-wide. We compared epidemiological and clinical outcomes of the four COVID-19 waves in the Democratic Republic of Congo (DRC). Methods This retrospective descriptive epidemiological analysis included data from the national line list of confirmed COVID-19 cases in all provinces for all waves between 9 March 2020 and 2 January 2022. Descriptive statistical measures (frequencies, percentages, case fatality rates [CFR], test positivity rates [TPR], and characteristics) were compared using chi-squared or the Fisher–Irwin test. Results During the study period, 72,108/445,084 (16.2%) tests were positive, with 9,641/56,637 (17.0%), 16,643/66,560 (25.0%), 24,172/157,945 (15.3%), and 21,652/163,942 (13.2%) cases during the first, second, third, and fourth waves, respectively. TPR significantly decreased from 17.0% in the first wave to 13.2% in the fourth wave as did infection of frontline health workers (5.2% vs. 0.9%). CFR decreased from 5.1 to 0.9% from the first to fourth wave. No sex- or age-related differences in distributions across different waves were observed. The majority of cases were asymptomatic in the first (73.1%) and second (86.6%) waves, in contrast to that in the third (11.1%) and fourth (31.3%) waves. Conclusion Despite fewer reported cases, the primary waves (first and second) of the COVID-19 pandemic in the DRC were more severe than the third and fourth waves, with each wave being associated with a new SARS-CoV-2 variant. Tailored public health and social measures, and resurgence monitoring are needed to control future waves of COVID-19.

Publisher

Springer Science and Business Media LLC

Reference50 articles.

1. World Health Organization. Coronavirus situational reports. 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200813-covid-19-sitrep-206.pdf?sfvrsn=bf38f66b_6. Accessed 24 Mar 2022.

2. Grainger R, Machado PM, Robinson PC. Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: epidemiology and outcomes. Best Pract Res Clin Rheumatol. 2021;35: 101657.

3. World Health Organization. COVID-19 Public Health Emergency of International Concern (PHEIC) Global research and innovation forum. WHO. 2020. https://www.who.int/publications/m/item/covid-19-public-health-emergency-of-international-concern-(pheic)-global-research-and-innovation-forum. Accessed 24 Mar 2022.

4. Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91:157–60.

5. World Health Organization. Coronavirus (COVID-19) dashboard. WHO Health Emergency Dashboard. WHO (COVID-19). 2022. https://covid19.who.int/. Accessed 3 Jul 2022.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3